Breathing Control in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Not Applicable

Completed

• Conditions: COPD
• Interventions: Behavioral: Breathing control

• Registration Number: NCT01512043
• Lead Sponsor: Lovisenberg Diakonale Hospital

Brief Summary

There is a demand for explorative and comparative studies on various non-pharmaceutical efforts in treating and helping chronic obstructive pulmonary disease patients. This study has been developed in light of this need. The main purpose of the project is to test whether a device guided breathing control system can decreasing the feeling of breathlessness in patients with moderate stage and severe stage of COPD. In addition the study could shed light on whether a reduced feeling of breathlessness can lead to improved physical function, and less experience of other symptoms (I.e., depression, anxiety, sleeping difficulties, fatigue, pain) and provide a better quality of life for patients with COPD.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-07
• Study First Submitted: 2011-12-08
• Study First Submitted QC: 2012-01-13
• Study First Posted: 2012-01-19
• Primary Completion: 2013-09
• Study Completion: 2013-09
• Status Verified: 2014-05
• Last Update Submitted: 2014-05-05
• Last Update Posted: 2014-05-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Dyspnoea symptoms in daily life
• Spirometry values showing a COPD moderate stage II (FEV1/FVC<70%, FEV1<80%) and severity grade at a severe stage III (FEV1/FVC<70%, FEV1<50% and FEV1 = 30% of a predicted)
• Be able to read, write and speak Norwegian
• Be at a stable phase of the disease

Exclusion Criteria

• Changes in pulmonary medication during the last 4 weeks
• Diagnosis of cancer
• Presently attending a pulmonary rehabilitation course or other similar COPD education courses (due to the fact that these courses often have instructions on breathing control), or having attended similar courses during the last six months
• Ongoing exacerbation
• Attending other competitive studies
• Diagnosis of neuromuscular disease
• Diagnosis of dementia
• Attending help from a pulmonary physiotherapist

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
2. Listening to music	Breathing control	Listening to music without guiding on breathing on the same device as breathing control twice a day for four weeks. Using the device to measure breathing movements.
1. Breathing control	Breathing control	Description ...
3. Silence	Breathing control	Using the device to measure breathing movement twice a day for four weeks. No instruction on breathing control and no music.

Primary Outcome Measures

Name	Time	Method
Breathlessness	4 months	Questionnaires

Secondary Outcome Measures

Name	Time	Method
Quality of life	4 months	Questionnaire
Depression	4 months	Questionnaires
Pulmonary functional tests	4 months
Fatigue	4 months	Questionnaire
Sleeping difficulties	4 months	Questionnaires
Pain	4 months	Questionnaire
Anxiety	4 months	Questionnaires
6. Min walk test	4 months
Arterial blood gas measures	4 months

Trial Locations

Locations (1)

Lovisenberg Diakonale Hospital; 🇳🇴 Oslo, Norway